drugset / Trial / NCT04642287

Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients

NCT04642287

RandomizedParallel-groupTriple-blindTreatment

Summary

This clinical trial aims to investigate the efficacy of Calcipotriol ointment combined with 5-FU cream in Organ Transplant Recipients (OTRs) to determine if it can stimulate the immune cells against actinic keratoses precancerous skin lesions after transplantation and prevent cutaneous squamous cell carcinoma (SCC) in long-term.

Timeline

Start
2026-01
Primary completion
2029-01
Completion
2030-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcipotriol Small molecule 0.0025 % Topical
Background fluorouracil Small molecule 2.5 % Topical